Search

everythinglearnresearchcommunity

for

Search:↓

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Patients often experience long-lasting changes to their hair after stem cell transplants.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Most pediatric inpatients needed dermatology consultations for unspecified rashes and drug reactions, with varied treatments.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Hair loss can be caused by stress, aging, and harmful substances that create an imbalance in the body's natural processes.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

The cream with plant components increased skin collagen and the hair tonic promoted hair growth in mice.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

The gel with apigenin and celery juice improved hair growth in rats without causing skin irritation.

Old hair follicles grew better when moved to a young environment.

Sarcoptes scabiei infection causes significant health and behavior changes in wombats.